# MOTS-c peptide FAQ: Side Effects, Safety, Dosing, and Legal Questions > MOTS-c peptide FAQ: direct, cited answers on side effects, safety, liver, weight, dosing frequency, onset, and legal status — every quantitative answer sourced to a published study or the audited FDA record. Direct answers, graded by evidence temperature and cited where a number is involved. ## What are the negative side effects of MOTS-c? No completed human safety trials exist, so there is no validated adverse-event profile in people [4]. Published work is in cells and animals; any claim about human side effects is unsupported by controlled data. For the regulatory and anti-doping context, see the [MOTS-c legal status and 503A access](/legal-status) page. ## What are the downsides of MOTS-c? The central limitation is evidence: there are no completed human efficacy or safety trials and no validated human pharmacokinetics, so rodent doses cannot be extrapolated [4]. It is a research chemical of variable, unregulated purity, and it is treated as a prohibited substance in elite sport. ## Can MOTS-c cause weight gain? In animal models MOTS-c did the opposite of promoting weight gain: it prevented diet-induced obesity and improved insulin sensitivity [1] and increased adipose thermogenesis. No human weight-outcome trials exist, so human effects are not established, and these mouse metabolic results should not be read as a human body-composition claim [4]. ## Is MOTS-c hard on the liver? No human hepatic-safety data have been published. The peptide's documented metabolic actions are AMPK-related improvements in glucose handling in animal models [1]; no hepatotoxicity has been demonstrated, but the absence of human safety trials means liver safety in people is uncharacterized [4]. ## Is MOTS-c bad for the liver? No human liver-safety data exist. The peptide's studied actions are AMPK-mediated metabolic effects in animal models [1], and no hepatotoxicity has been reported in that work; but with no completed human trial, liver safety in people has not been characterized one way or the other [4]. ## How does MOTS-c make you feel? There are no controlled human studies of subjective effects. The literature characterizes molecular and physiological actions in cells and animals — AMPK activation, glucose uptake, exercise capacity [1][2] — not self-reported human experiences, so any account of how MOTS-c "feels" sits outside the published evidence. ## What should you not mix with peptides? No controlled human interaction studies for MOTS-c have been published. Mechanistically it activates AMPK [1], a pathway also engaged by some metabolic agents; any combination is unstudied in humans and outside the scope of this research digest. Questions about combinations belong with a qualified clinician, not a literature digest. ## What are the top peptides for muscle growth? MOTS-c is studied for muscle preservation rather than hypertrophy: in animal and cell models it reduces myostatin and atrophy signaling [6] and counters disuse- and glucocorticoid-induced muscle loss [11][13]. It is a mitochondrial-derived signaling peptide, not an anabolic agent, and these effects are preclinical, not demonstrated human muscle growth. ## Can MOTS-c prevent muscle loss during inactivity or aging? In mice, MOTS-c attenuated immobilization-induced skeletal-muscle atrophy by suppressing intramuscular lipid infiltration [13], and a 2024 study showed tissue-specific CK2 modulation prevents muscle atrophy while enhancing muscle glucose uptake [9]. In cultured human muscle cells it, with humanin, attenuated dexamethasone-induced atrophy [11]. All findings are preclinical. ## What does the MOTS-c peptide do? MOTS-c inhibits the folate cycle and de novo purine biosynthesis, raising AICAR and activating AMP-activated protein kinase (AMPK), which improves glucose handling and insulin sensitivity primarily in skeletal muscle in animal models [1]. Under metabolic stress it also translocates to the nucleus and regulates stress-response genes [3]. ## What are the potential benefits of MOTS-c? Studied effects in cell and animal models include improved insulin sensitivity and glucose handling, prevention of diet-induced obesity, enhanced physical performance, prevention of muscle atrophy, and stress-adaptive gene regulation [1][2][6][9]. These are reported effects in research models, not demonstrated human benefits; the human evidence base is observational and biomarker-level only [10]. ## Does MOTS-c burn fat? In mice, MOTS-c prevented diet-induced obesity and increased adipose thermogenic activation, and it reshaped the plasma metabolome while enhancing insulin sensitivity [1]. The mechanism is AMPK-centered glucose handling rather than a direct fat-burning drug action. These are animal-model metabolic effects; no human fat-loss trial has been completed [4]. ## How often do you inject MOTS-c? There is no validated human dosing schedule. Published rodent studies used repeated regimens such as daily IP injection [1] or 15 mg/kg three times per week IP [2]; the frequent dosing reflects a short-lived peptide in mice. These are animal-research protocols, not human dosing guidance. ## Can I inject MOTS-c every day? Rodent studies used both daily and thrice-weekly IP regimens [1][2]. There is no validated human dosing schedule of any frequency, and these animal protocols were designed to study a short-lived peptide in mice — they are not a recommendation for human use, daily or otherwise. ## How long should you take MOTS-c? Published animal studies ran for varying durations — for example, roughly 8 weeks in metabolic models [1] and up to 12 weeks in a bone study. These describe experiment lengths in mice, not a regimen; no human treatment duration has been established in any completed trial [4]. ## Where is best to inject MOTS-c? There is no validated human injection-site guidance. In published animal studies MOTS-c was given by intraperitoneal injection — into the abdominal cavity, a standard rodent route [1][2]; subcutaneous injection appears in the broader research context. These are research routes in animals, not instructions for human use. ## How long does it take for MOTS-c to kick in? No human time-to-effect data exist. Animal metabolic studies dosed chronically over weeks before measuring endpoints [1], while an acute exercise-performance benefit was reported after a single dose in mice [5]. The timeframe depends entirely on the endpoint, and none of this defines a human onset. ## How long does MOTS-c take to work? It varies by endpoint and is documented only in animals: animal studies used chronic dosing over several weeks for metabolic endpoints [1], while an acute single-dose improvement in exercise performance was reported in mice [5]. No human time-to-effect has been measured, so these animal timeframes cannot be read as human expectations. ## Does MOTS-c work immediately? It depends on the endpoint, and only in animals: a single dose improved acute exercise performance in mice [5], but the metabolic and anti-obesity endpoints in animal studies required chronic dosing over weeks [1]. No human onset data exist, so neither timeframe transfers to people. ## Is MOTS-c legal to buy? MOTS-c is not FDA-approved for any human use and is sold only as a research chemical for laboratory use, with no approved indication, formulation, or dosing. It is also treated as a prohibited substance in elite sport by anti-doping bodies (USADA/WADA). See [MOTS-c legal status and 503A access](/legal-status). ## Can I get MOTS-c over the counter? No. MOTS-c is not an approved drug or a dietary supplement; it is sold only as a research chemical for laboratory use. There is no over-the-counter or approved human product, and no approved indication, formulation, or dosing exists for it [18]. ## Where can I buy MOTS-c peptide online in the USA? MOTS-c is sold only as a research chemical for laboratory use, not as an approved human medicine or supplement; this site is a research digest and does not sell it or recommend any supplier. See the regulatory and FDA 503A context on the [MOTS-c legal status and 503A access](/legal-status) page. ## Is MOTS-c legal? MOTS-c is not an FDA-approved drug for any indication and is sold only as a research chemical for laboratory use [18]. It is individually named on the FDA PCAC agenda for July 23–24, 2026 as a substance being considered for the 503A bulks list — a scheduled discussion, not a decision [18]. It is also treated as prohibited in elite sport. ## Can you get MOTS-c from a compounding pharmacy? A 503A pharmacy may compound from a bulk substance only if that substance has a USP/NF monograph, is a component of an FDA-approved drug, or is on FDA's 503A bulks list [16]. MOTS-c is not FDA-approved and is scheduled for PCAC evaluation rather than being on the bulks list; being under evaluation is not the same as being eligible for routine compounding [18]. ## What is the FDA 503A status of MOTS-c? MOTS-c is not an FDA-approved drug and is scheduled for PCAC evaluation; it is named on the published agenda of the July 23–24, 2026 PCAC meeting as a substance being considered for inclusion on the 503A bulks list, in free base and acetate forms [18]. The audited FDA record does not place MOTS-c in a numbered 503A category, so none is stated here. This is a scheduled evaluation, not a listing decision [16][18]. --- A thermographic read of the MOTS-c record — each finding logged at the temperature its data actually run and the research-use and FDA standing read before anything else; no clinic behind the instrument and nothing here dispensed or sold.